Abstract. Cases of melioidosis and glanders are rare in the United States, but the etiologic agents of each disease (Burkholderia pseudomallei and Burkholderia mallei, respectively) are classified as Tier 1 select agents because of concerns about their potential use as bioterrorism agents. A rapid, highly sensitive, and portable assay for clinical laboratories and field use is required. Our laboratory has further evaluated a latex agglutination assay for its ability to identify B. pseudomallei and B. mallei isolates. This assay uses a monoclonal antibody that specifically recognizes the capsular polysaccharide produced by B. pseudomallei and B. mallei, but is absent in closely related Burkholderia species. A total of 110 B. pseudomallei and B. mallei were tested, and 36 closely related Burkholderia species. The latex agglutination assay was positive for 109 of 110 (99.1% sensitivity) B. pseudomallei and B. mallei isolates tested.
The Gram-negative bacteria Burkholderia pseudomallei and Burkholderia mallei are the etiologic agents of melioidosis and glanders, respectively. Melioidosis typically causes disease in humans and is endemic to Southeast Asia and northern Australia, whereas glanders is a disease most commonly seen in horses, mules, and donkeys in the Middle East, Africa, and India. Both bacteria are of concern because of their potential use as bioterrorism agents. The rarity of both diseases in the United States and other countries where the diseases are not endemic could delay proper diagnosis by physicians and laboratory staff during a bioterrorism event caused by responders' unfamiliarity with the diseases. Diagnostic confirmation of both diseases relies on microbiological culture. However, B. pseudomallei is commonly dismissed as a culture contaminant, and along with B. mallei may be misidentified by standard identification methods including API 20NE and other automated bacterial identification systems. Therefore, rapid diagnostic tools for bacterial identification are essential to provide an effective response by public health authorities in the event of a bioterrorism incident. The goal of this study was to evaluate a rapid assay for the identification of B. pseudomallei and B. mallei.
Latex agglutination assays have been used successfully in Southeast Asia and northern Australia to identify B. pseudomallei isolates and closely related species. 1 Assays such as these are based on the use of monoclonal antibodies (MAbs) that recognize an exopolysaccharide present on the cell surface of B. pseudomallei and B. mallei. [2] [3] [4] Nonetheless, these assays are normally evaluated with limited strains isolated from endemic areas, and its use for strains isolated from all other countries has not been adequately evaluated. [2] [3] [4] Our laboratory has evaluated a rapid latex agglutination assay developed by Mahidol University (Bangkok, Thailand) using an inclusivity panel of 110 geographically and genetically diverse B. pseudomallei and B. mallei isolates, stored at The Centers for Disease Control and Prevention (CDC), Atlanta, GA. We also evaluated the assay with an exclusivity panel of 36 closely related Burkholderia species, which included agents that have not been previously tested by this or similar antigen detection assays. We focused on the closest phylogenetic relatives of B. pseudomallei including other Burkholderia species that have been associated with human disease such as Burkholderia oklahomensis and Burkholderia gladioli. Burkholderia oklahomensis has been reported to cause infections associated with deep tissue wounds, 5, 6 whereas B. gladioli can cause a range of diseases from fatal foodborne illness, 7 to sepsis in newborns, 8 and lung infections in patients with cystic fibrosis. 9 This latex agglutination assay could be valuable in correctly identifying select agents and excluding closely related Burkholderia species that cause similar disease in humans.
The antibody-latex suspension based on the 4B11 monoclonal antibody was prepared by Mahidol University as previously described. [2] [3] [4] The assay was performed also as previously described with slight modification. 1 Briefly, isolates were subcultured twice on trypticase soy agar (TSA) containing 5% sheep's blood and incubated for 18-24 hours at 37 C. Single colonies were picked and added to 10 μL of the latex suspension on a ringed glass microscope slide. The glass slide containing the latex suspension with the suspended colony was subjected to gentle rocking for 2 minutes after which time the reaction was recorded as either positive (agglutination) or negative (no agglutination) ( Figure 1 ). Burkholderia pseudomallei K96243 was used as the positive control in all experiments and Burkholderia thailandensis E264 (American Type Culture Collection [ATCC] type strain 700388) was used as the negative control each time isolates were tested, and all tests were performed in triplicate.
*Address correspondence to Alex R. Hoffmaster, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, MS-G34, Atlanta, GA 30333. E-mail: amh9@cdc.gov Under our assay conditions, the latex agglutination test was positive on 109 of 110 (99.1% sensitivity) isolates tested on the inclusivity panel. This number included a total of 77 B. pseudomallei isolates, of which 76 (98.7% sensitivity) were positive and 33 B. mallei isolates of which all were positive (100% sensitivity) ( Table 1 ). The B. pseudomallei isolate that tested negative in our assay, CDC2721686 (MSHR1655), was isolated from a patient with a chronic B. pseudomallei infection after being first diagnosed with melioidosis in 2000. 10 This rare B. pseudomallei isolate was from the patient in an ongoing study consisting of 815 patients that were culturepositive for melioidosis in Darwin, Australia. Since 1989, this patient is the only survivor from this study to remain chronically colonized by B. pseudomallei. CDC2721686 (MSHR1655) was isolated 37 months after the initial melioidosis diagnosis and has undergone major genome-wide rearrangements resulting in a loss of function in many genes that are important in pathogenesis. Of particular interest to this study is the loss of function of wcbR, which encodes an essential fatty acid synthase required in capsular polysaccharide synthesis. 11 We believe this would explain the inability of the latex agglutination assay to correctly identify this isolate. In addition to testing negative in our assay, when subjected to standard biochemical tests for the identification of B. pseudomallei, the isolate was non-motile, but otherwise normal under our assay conditions. When the latex agglutination assay was tested against an exclusivity panel of closely related Burkholderia species, 35 of 36 (97.2% specificity) yielded negative results ( Table 2 ). The closely related Burkholderia that tested positive in our assay is a rare variant of B. thailandensis (CDC3015869, TX DOH) that has been previously described as containing B. pseudomallei capsule genes. 12 Rapid diagnostic assays, such as the one we have evaluated, would have the most impact in clinical laboratories. This would allow for early identification of suspect isolates and thus on-site diagnosis instead of needing to submit samples to regional laboratories that would delay results. This assay does have several advantages over the current reference level testing. This assay is simple, does not require extra equipment, and can easily be performed. However, the extent to which this assay or similar antigen detection assays can be used on patient samples is yet to be determined. 
